HistoPlex
Natural health product licensed in Canada
- Licence holder
- Biotics Research Corporation
- NPN or DIN-HM
- 80045241
- Status
- Active licence
- Licence date
- 3 October 2013
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Andrographis paniculata (Burm. f.) Nees: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Ligusticum porteri Source : Racine | 120 mg | Not calculated |
| Andrographis paniculata Source : Sommité Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 250 mg | 25 mg | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Gélatine, Eau
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 2 Capsule ; maximum: 3 Capsule | 1 day |
Uses authorised in Canada
DMG is an intermediate in the metabolism of the non-essential amino acid glycine, which is involved in protein synthesis. Hesperidin is an antioxidant for the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Hypersensitivity (e.g., allergy) has been known to occur, in which case discontinue use. Stop use and seek medical attention immediately if you experience dizziness, confusion, muscle weakness or pain, abnormal heartbeat and/or difficulty breathing. Discontinue use if nausea, vomiting or urticaria occurs.
- Précautions et mises en garde
Consult a health care practitioner prior to use if you have diabetes, or if you are taking blood-pressure medications or blood thinners. Consult a health care practitioner prior to use if you are taking any prescription medications. Consult a health care practitioner prior to use in the case of an estrogen-dependent cancer.
Source
Official Health Canada record, licence 80045241
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.